RCAMU
EGRX

Rothschild & Co Asset Management US’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Rothschild & Co Asset Management US’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-161,444
Closed -$6.51M – 383
2018
Q4 		$6.51M Sell
161,444
-238,793
-60% -$9.62M 0.08% 284
2018
Q3 		$27.7M Sell
400,237
-7,314
-2% -$507K 0.28% 146
2018
Q2 		$30.8M Buy
+407,551
New +$30.8M 0.33% 110